Metastatic Colorectal Cancer Pipeline Insight Analysis 2024, Featuring Emerging Drugs Mirati Therapeutics Adagrasib, Qilu Pharmaceutical QL-1203 and Zentalis Pharmaceuticals ZN-c3
April 25, 2024 04:05 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Metastatic colorectal cancer - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
Global Colorectal Cancer Pipeline Insights Report for 2024: An In-Depth Analysis of Clinical and Nonclinical Developments
April 23, 2024 07:28 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Colorectal Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The world is seeing an unprecedented increase...
Global Colorectal Cancer Drugs Market to Reach USD 12.79 Billion by 2028 with Notable CAGR of 4.57%
March 28, 2024 11:19 ET
|
Research and Markets
Dublin, March 28, 2024 (GLOBE NEWSWIRE) -- The "Global Colorectal Cancer Drugs Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis."...
Global $6.85 Bn Colorectal Cancer Drugs Markets, 2015-2020, 2020-2025F, 2030F
July 09, 2021 04:58 ET
|
Research and Markets
Dublin, July 09, 2021 (GLOBE NEWSWIRE) -- The "Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering....
US Colorectal Cancer Market and Competitive Landscape 2021 - Pipeline Products, Market Analysis, Epidemiology, Key Products Marketed, Market Valuations & Forecast, Drugs Sales and Market Shares
January 22, 2021 05:43 ET
|
Research and Markets
Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "US Colorectal Cancer Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This research report...